• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters1
Displaying 174-188 of 313 results

1008 Exhibit: US Patent Publ No 20100029781

Document IPR2019-00207, No. 1008-7 Exhibit - US Patent Publ No 20100029781 (P.T.A.B. Nov. 6, 2018)
Log in to see more
cite Cite Document
Analyze

1018 Exhibit: Gilmore Declaration

Document IPR2019-00207, No. 1018-31 Exhibit - Gilmore Declaration (P.T.A.B. Nov. 6, 2018)
And I understand from Counsel that the references themselves need not provide a specific teaching or suggestion of the alteration needed to arrive at the Inter Partes Review of U.S. Patent No. 9,517,219 Declaration of Elaine S. Gilmore, M.D., Ph.D. (Exhibit 1018) claimed invention; the analysis may include recourse to logic, judgment, and common sense available to a person of ordinary skill that does not necessarily require an explicit teaching, suggestion, or motivation in any reference.
without a certification in dermatology (i.e., a primary care physician, or a pediatrician) may qualify as a clinical POSA, assuming that they have more than two years of knowledge and experience treating skin conditions.
I have been informed by Counsel that the proper construction of the claims in this proceeding Inter Partes Review of U.S. Patent No. 9,517,219 Declaration of Elaine S. Gilmore, M.D., Ph.D. (Exhibit 1018) is the “broadest reasonable interpretation” in light of the patent’s specification.
(AMN1004, 1) A POSA in 2012 would understand that Garrett teaches methods of treating both rosacea and acne consisting of inflammatory and non-inflammatory lesions by applying topical compositions containing dapsone to a patient’s affected areas.
First, the reduction in number of daily applications is not unexpected, as dermatologists expected at the time of invention that the potency, or strength, of a given drug is related to both its duration of action and its side effects.
cite Cite Document
Analyze

2034 Exhibit: Exhibit 2034 Tanghetti et al 2011

Document IPR2019-00207, No. 2034-65 Exhibit - Exhibit 2034 Tanghetti et al 2011 (P.T.A.B. Aug. 9, 2019)
Log in to see more
cite Cite Document
Analyze

2025 Exhibit: Exhibit 2025 Kraft et al 2011

Document IPR2019-00207, No. 2025-56 Exhibit - Exhibit 2025 Kraft et al 2011 (P.T.A.B. Aug. 9, 2019)
Log in to see more
cite Cite Document
Analyze

2010 Exhibit: Exhibit 2010 Collier et al 2008

Document IPR2019-00207, No. 2010-41 Exhibit - Exhibit 2010 Collier et al 2008 (P.T.A.B. Aug. 9, 2019)
Log in to see more
cite Cite Document
Analyze

2021 Exhibit: Exhibit 2021 Kircik et al 2010a

Document IPR2019-00207, No. 2021-52 Exhibit - Exhibit 2021 Kircik et al 2010a (P.T.A.B. Aug. 9, 2019)

cite Cite Document
Analyze

2050 Exhibit: Exhibit 2050 FDA Inactive Ingredient Database September 2012

Document IPR2019-00207, No. 2050-81 Exhibit - Exhibit 2050 FDA Inactive Ingredient Database September 2012 (P.T.A.B. Aug. 9, 2019)

cite Cite Document
Analyze

2055 Exhibit: Exhibit 2055 Kircik Decl ISO Patent Owners Response

Document IPR2019-00207, No. 2055-86 Exhibit - Exhibit 2055 Kircik Decl ISO Patent Owners Response (P.T.A.B. Aug. 9, 2019)

cite Cite Document
Analyze

2037 Exhibit: Exhibit 2037 Thielitz et al 2008

Document IPR2019-00207, No. 2037-68 Exhibit - Exhibit 2037 Thielitz et al 2008 (P.T.A.B. Aug. 9, 2019)

cite Cite Document
Analyze

3002 Exhibit: Ex 3002

Document IPR2019-00207, No. 3002-150 Exhibit - Ex 3002 (P.T.A.B. Aug. 20, 2020)

cite Cite Document
Analyze

1074 Exhibit: Aczone DFD

Document IPR2019-00207, No. 1074-132 Exhibit - Aczone DFD (P.T.A.B. Nov. 1, 2019)

cite Cite Document
Analyze

1064 Exhibit: Kircik DFD 2014

Document IPR2019-00207, No. 1064-122 Exhibit - Kircik DFD 2014 (P.T.A.B. Nov. 1, 2019)

cite Cite Document
Analyze

1052 Exhibit: DMF approval database

Document IPR2019-00207, No. 1052-113 Exhibit - DMF approval database (P.T.A.B. Nov. 1, 2019)

cite Cite Document
Analyze

1041 Exhibit: Allergan Announces Agreement to Acquire Aczone¿¿ Gel

Document IPR2019-00207, No. 1041-105 Exhibit - Allergan Announces Agreement to Acquire Aczone¿¿ Gel (P.T.A.B. Nov. 1, 2019)

cite Cite Document
Analyze

1035 Exhibit: Poster Abstracts for the Journal of the American Academy of Dermat...

Document IPR2019-00207, No. 1035-98 Exhibit - Poster Abstracts for the Journal of the American Academy of Dermatology 2017 Annual Meeting served October 4, 2019 Part 3 (P.T.A.B. Oct. 18, 2019)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 12 13 14 15 16 ... >>